Justin B. Klee, Co-CEO: Amylyx Pharmaceuticals AMLX Sell · Filed 03/04

Trade details

Type: Insider sale
Amount: $423,710.54
Shares · price: 29,282 sh · $14.47 a share
Held after: 3,334,616 sh
Stock: Amylyx Pharmaceuticals AMLX
Person: Justin B. KleeCo-CEO
Trade date: 26/03/02
Filed: 26/03/04
Days to filing: 2 days

Sold 0.9% of holdings

Share of holding sold: 0.9%

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/31~04/01

Justin B. Klee's recent trades

Justin B. KleeCo-CEO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$980.3K
30,464 sh
$980.3K
Filed 09/11
Traded 09/10
Justin B. KleeCo-CEO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$423.8K
29,282 sh
$423.8K
Filed 03/02
Traded 03/02
Justin B. KleeCo-CEO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$227.7K
15,500 sh
$227.7K
Filed 02/04
Traded 02/02
Justin B. KleeCo-CEO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$227.6K
15,500 sh
$227.6K
Filed 02/02
Traded 02/02
Justin B. KleeCo-CEO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$1.8M
136,193 sh
$1.8M
Filed 01/20
Traded 01/15